Search results
Added:
5 years ago
Dr Nicolas van Mieghem and Dr Joost Daemen (Erasmus MC, Rotterdam, NL) discuss and analyse the late-breaking trials at AHA 2018.
View more
ACC 2018: TRIUMPH Trial
Added:
5 years ago
Video
Added:
3 years ago
Diabetes and Cardiovascular Disease
Diabetes has long been recognized as a major risk factor for cardiovascular disease and is widely regarded as a ‘coronary disease equivalent,’1,2 as diabetes and established coronary heart disease indicate a similar absolute risk for cardiovascular death in both men and women.3–5 Cardiovascular complications of diabetes have traditionally been regarded as…
View more
Added:
5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker
Filmed on-site at ESC 2018 by Radcliffe Cardiology.
View more
Added:
1 year ago
Added:
4 years ago
Prof Matthew Budoff (David Geffen School of Medicine at UCLA, Los Angeles, CA, US) discusses the effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499 mg/dl) on Statin Therapy (EVAPORATE Study)
Filmed on site at AHA 2019 by Radcliffe Cardiology.
Videographer: Tom Green & Dominic Woodruff
View more
Added:
6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Randomized Placebo-Controlled Trial of Anacetrapib in 30,449 Patients with Atherosclerotic Vascular Disease (REVEAL).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Added:
4 years ago
Prof Sripal Bangalore (NYU School of Medicine, New York, NY, US)provides anInternational Study of Comparative Health Effectiveness With Medical and Invasive Approaches, giving updates from ISCHEMIA-CKD (Chronic Kidney Disease) - primary results of clinical outcomes.
Filmed on-site at AHA 2019 by Radcliffe Cardiology.
Videographer: Tom Green & Dominic Woodruff
View more
Added:
5 years ago
Whether you are attending or not, watch Dr Nicolas Van Mieghem and Dr Joost Daemen analyse what to expect from this year's late breaking trials at #ACC19 in the latest instalment of ‘View from the Thoraxcenter’. Topics covered include wearable technology, low-risk TAVI/R, mitraclip, anticoagulation, DAPT, coronary physiology, hypertension and heart failure.
Trials covered in this video:
00:33 -…
View more
Added:
3 years ago
Dr Marc P Bonaca (University of Colorado, Aurora, CO, US) discusses the results of the THEMIS trial focusing on the THEMIS-PAD substudy.
THEMIS compared the effect of ticagrelor versus placebo in patients with Type 2 Diabetes. The purpose of the substudy was to evaluate ticagrelor/aspirin compared with placebo/aspirin among patients with stable coronary artery disease and type 2 diabetes.
…
View more
« First